Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Roivant Sciences combination with Montes Archimedes Acquisition
We are advising Roivant Sciences on its combination with a SPAC
Olam Food Ingredients $950 million acquisition of Olde Thompson
We are advising Olam Food Ingredients on the acquisition
VF sells occupational portion of its work segment to Redwood Capital
We are advising VF on the sale
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
FirstGroup $4.6 billion sale of First Student and First Transit to EQT
We are advising FirstGroup on the divestitures
UiPath $1.54 billion IPO
The shares are listed on the New York Stock Exchange
Akoya Biosciences $151.3 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Recursion Pharmaceuticals $500 million IPO
We advised the underwriters on the IPO and Nasdaq listing
TuSimple $1.35 billion IPO
The shares are listed on the Nasdaq Global Select Market
Alkami Technology $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing